SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-12-050166
Filing Date
2012-09-07
Accepted
2012-09-07 16:01:47
Documents
7
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A v320947_10qa.htm 10-Q/A 21709
  Complete submission text file 0001144204-12-050166.txt   3314770

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT tgtxd-20120630.xml EX-101.INS 418787
3 XBRL TAXONOMY EXTENSION SCHEMA tgtxd-20120630.xsd EX-101.SCH 41802
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtxd-20120630_cal.xml EX-101.CAL 29907
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtxd-20120630_def.xml EX-101.DEF 204767
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtxd-20120630_lab.xml EX-101.LAB 344716
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtxd-20120630_pre.xml EX-101.PRE 252331
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-32639 | Film No.: 121080110
SIC: 2834 Pharmaceutical Preparations